| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2,421,216 | 3.1% | $97.00 | +$234,857,952 |
| Sells | 3 | -75,963,699 | 97% | $96.95 | -$7,364,858,139 |
| Net | -2 | -73,542,483 | -94% | -$7,130,000,187 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | 10%+ Owner | $6,467,225 | 07 Oct 2021 | ||
| Sven Ante Lundberg | President, CEO & PEO, Director | $4,226,622 | 12 Dec 2025 | ||
| Hui Liu | EVP, CBO & Head of Merus US | $1,450,696 | 07 May 2024 | ||
| GREGORY D. PERRY | Chief Financial Officer & PFO | $1,450,696 | 12 Dec 2025 | ||
| Andrew Joe | Svp, Cmo | $1,450,696 | 07 May 2024 | ||
| Peter B. Silverman | Coo & Gc | $1,450,696 | -$4,586,340 | -76% | 12 Dec 2025 |
| Cecile A. W. Geuijen | SVP & Chief Scientific Officer | $743,600 | 31 Jan 2022 | ||
| John de Kruif | SVP & Chief Technology Officer | $743,600 | 31 Jan 2022 | ||
| Lex Bakker | SVP, Chief Development Officer | $743,600 | 31 Jan 2022 | ||
| Harry Shuman | VP Controller, PAO | $372,476 | -$1,153,496 | -76% | 12 Dec 2025 |
| Jason Haddock | Director | $239,142 | 12 Dec 2025 | ||
| Victor Sandor | Director | $119,571 | 12 Dec 2025 | ||
| Paolo Pucci | Director | $119,571 | 12 Dec 2025 | ||
| Iwicki Mark T. | Director | $119,571 | 12 Dec 2025 | ||
| Anand Mehra | Director | $119,571 | 12 Dec 2025 | ||
| MAXINE GOWEN | Director | $119,571 | 12 Dec 2025 | ||
| Len Kanavy | Director | $119,571 | 12 Dec 2025 | ||
| GENMAB A/S | 10%+ Owner | $0 | -$7,124,260,351 | -100% | 26 Dec 2025 |
| Fabian Zohren | Chief Medical Officer | 12 Dec 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|